Dr Reddy's Laboratories (NSE:DRREDDY) Cyclically Adjusted Book per Share: ₹291.31 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DRREDDY Dr Reddy's Laboratories Ltd NSE:DRREDDY
93 GF Score
Price ₹1,246.20
GF Value ₹1,411.54
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dr Reddy's Laboratories Cyclically Adjusted Book per Share?

Dr Reddy's Laboratories NSE:DRREDDY +0.95% 93 Cyclically Adjusted Book per Share is ₹291.31 as of Mar. 2026. GuruFocus rates NSE:DRREDDY with a GF Score™ of 93/100 and a GF Value™ of ₹1,411.54 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dr Reddy's Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was ₹452.825. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹291.31 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Dr Reddy's Laboratories's average Cyclically Adjusted Book Growth Rate was 12.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Dr Reddy's Laboratories was 14.20% per year. The lowest was 8.90% per year. And the median was 12.00% per year.

As of today (2026-07-15), Dr Reddy's Laboratories's current stock price is ₹1246.20. Dr Reddy's Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹291.31. Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio of today is 4.28.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr Reddy's Laboratories was 6.94. The lowest was 3.25. And the median was 4.66.


Dr Reddy's Laboratories  (NSE:DRREDDY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1246.20/291.31
=4.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr Reddy's Laboratories was 6.94. The lowest was 3.25. And the median was 4.66.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dr Reddy's Laboratories Cyclically Adjusted Book per Share Related Terms


Dr Reddy's Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Dr Reddy's Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories Cyclically Adjusted Book per Share Chart

Dr Reddy's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186.79 210.60 234.81 259.46 291.31

Dr Reddy's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.46 267.92 277.33 284.31 291.31

NSE:DRREDDY vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio falls into.


NSE:DRREDDY
93GF Score
Dr Reddy's Laboratories Ltd NSE:DRREDDY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Reddy's Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr Reddy's Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=452.825/164.2724*164.2724
=452.825

Current CPI (Mar. 2026) = 164.2724.

Dr Reddy's Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 137.875 105.961 213.749
201609 139.115 105.961 215.671
201612 146.072 105.196 228.104
201703 149.683 105.196 233.743
201706 148.880 107.109 228.337
201709 146.902 109.021 221.351
201712 149.114 109.404 223.898
201803 152.443 109.786 228.099
201806 157.170 111.317 231.939
201809 158.349 115.142 225.916
201812 163.643 115.142 233.469
201903 169.067 118.202 234.962
201906 176.455 120.880 239.798
201909 185.602 123.175 247.528
201912 179.374 126.235 233.423
202003 186.985 124.705 246.313
202006 195.039 127.000 252.279
202009 199.338 130.118 251.662
202012 204.168 130.889 256.241
202103 208.853 131.771 260.368
202106 214.817 134.084 263.182
202109 221.069 135.847 267.327
202112 228.362 138.161 271.521
202203 229.610 138.822 271.705
202206 241.459 142.347 278.650
202209 248.437 144.661 282.117
202212 265.228 145.763 298.908
202303 278.040 146.865 310.996
202306 295.121 150.280 322.599
202309 304.033 151.492 329.682
202312 321.716 152.924 345.590
202403 336.940 153.035 361.683
202406 353.810 155.789 373.077
202409 366.539 157.882 381.374
202412 381.362 158.323 395.693
202503 400.705 157.552 417.798
202506 420.556 159.755 432.448
202509 430.610 162.289 435.872
202512 447.250 163.281 449.966
202603 452.825 164.272 452.825

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹291.31 mean?
Dr Reddy's Laboratories (NSE:DRREDDY) has a Cyclically Adjusted Book per Share of ₹291.31 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr Reddy's Laboratories and its competitors.
Is Dr Reddy's Laboratories' Cyclically Adjusted Book per Share too high?
Dr Reddy's Laboratories' current Cyclically Adjusted Book per Share is ₹291.31. Overall, Dr Reddy's Laboratories has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Reddy's Laboratories' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Dr Reddy's Laboratories' Cyclically Adjusted Book per Share of ₹291.31 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr Reddy's Laboratories and its competitors. Dr Reddy's Laboratories's current Cyclically Adjusted Book per Share is ₹291.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Reddy's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Dr Reddy's Laboratories (NSE:DRREDDY) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,411.54, compared to a current price of ₹1,246.20 — trading 11.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₹291.31. Dr Reddy's Laboratories' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Dr Reddy's Laboratories (NSE:DRREDDY), the current Cyclically Adjusted Book per Share is ₹291.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Reddy's Laboratories (NSE:DRREDDY) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Reddy's Laboratories stock appears to be undervalued. The current stock price of ₹1,246.20 is trading 11.7% below its estimated GF Value™ of ₹1,411.54. GuruFocus considers Dr Reddy's Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:DRREDDY:

  • Cyclically Adjusted Book per Share: ₹291.31
  • GF Value™: ₹1,411.54 vs. price of ₹1,246.20 (11.7% below fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the NSE:DRREDDY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Reddy's Laboratories Business Description

Address 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
93GF Score

Get the complete analysis for NSE:DRREDDY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,246.20
Price
₹1,411.54
GF Value